Kurs
-5,83%
Likviditet
0,22 MNOK
Kalender
| Est. tid* | ||
| 2025-08-27 | 12:50 | Kvartalsrapport 2025-Q2 |
| 2025-06-26 | - | X-dag ordinarie utdelning ABTEC 0.00 NOK |
| 2025-06-25 | - | Årsstämma |
| 2025-05-02 | - | Bokslutskommuniké 2024 |
| 2025-04-09 | - | Extra Bolagsstämma 2025 |
| 2024-11-13 | - | Extra Bolagsstämma 2024 |
| 2024-08-23 | - | Kvartalsrapport 2024-Q2 |
| 2024-07-01 | - | X-dag ordinarie utdelning ABTEC 0.00 NOK |
| 2024-06-28 | - | Årsstämma |
| 2024-06-14 | - | Bokslutskommuniké 2023 |
| 2023-08-24 | - | Kvartalsrapport 2023-Q2 |
| 2023-06-12 | - | X-dag ordinarie utdelning ABTEC 0.00 NOK |
| 2023-06-09 | - | Årsstämma |
| 2023-04-28 | - | Bokslutskommuniké 2022 |
| 2022-08-24 | - | Kvartalsrapport 2022-Q2 |
| 2022-06-10 | - | X-dag ordinarie utdelning ABTEC 0.00 NOK |
| 2022-06-09 | - | Årsstämma |
| 2022-04-29 | - | Bokslutskommuniké 2021 |
| 2021-08-25 | - | Kvartalsrapport 2021-Q2 |
| 2021-06-10 | - | X-dag ordinarie utdelning ABTEC 0.00 NOK |
| 2021-06-09 | - | Årsstämma |
| 2021-04-30 | - | Bokslutskommuniké 2020 |
| 2020-09-11 | - | Extra Bolagsstämma 2020 |
| 2020-08-26 | - | Kvartalsrapport 2020-Q2 |
| 2020-06-11 | - | X-dag ordinarie utdelning ABTEC 0.00 NOK |
| 2020-06-10 | - | Årsstämma |
| 2020-04-15 | - | Bokslutskommuniké 2019 |
| 2019-08-28 | - | Kvartalsrapport 2019-Q2 |
| 2019-06-06 | - | X-dag ordinarie utdelning ABTEC 0.00 NOK |
| 2019-06-05 | - | Årsstämma |
| 2019-04-24 | - | Bokslutskommuniké 2018 |
| 2019-01-07 | - | Extra Bolagsstämma 2019 |
| 2018-08-22 | - | Kvartalsrapport 2018-Q2 |
| 2018-05-30 | - | Årsstämma |
| 2018-02-21 | - | Bokslutskommuniké 2017 |
| 2017-08-16 | - | Kvartalsrapport 2017-Q2 |
| 2017-06-08 | - | X-dag ordinarie utdelning ABTEC 1.00 NOK |
| 2017-06-07 | - | Årsstämma |
| 2017-02-15 | - | Bokslutskommuniké 2016 |
| 2016-11-18 | - | X-dag bonusutdelning ABTEC 1 |
| 2016-11-17 | - | Extra Bolagsstämma 2016 |
| 2016-11-17 | - | 15-10 2016-Q3 |
| 2016-08-17 | - | Kvartalsrapport 2016-Q2 |
| 2016-06-09 | - | X-dag ordinarie utdelning ABTEC 1.50 NOK |
| 2016-06-08 | - | Årsstämma |
| 2016-02-10 | - | Bokslutskommuniké 2015 |
| 2015-11-18 | - | Kvartalsrapport 2015-Q3 |
| 2015-08-19 | - | Kvartalsrapport 2015-Q2 |
| 2015-06-04 | - | X-dag ordinarie utdelning ABTEC 1.00 NOK |
| 2015-06-03 | - | Årsstämma |
| 2015-05-13 | - | Kvartalsrapport 2015-Q1 |
| 2015-02-11 | - | Bokslutskommuniké 2014 |
| 2014-11-26 | - | Kvartalsrapport 2014-Q3 |
| 2014-08-20 | - | Kvartalsrapport 2014-Q2 |
| 2014-06-11 | - | Årsstämma |
| 2014-05-21 | - | Kvartalsrapport 2014-Q1 |
| 2014-02-12 | - | Bokslutskommuniké 2013 |
| 2013-11-27 | - | Kvartalsrapport 2013-Q3 |
| 2013-08-21 | - | Kvartalsrapport 2013-Q2 |
| 2013-06-13 | - | Kapitalmarknadsdag 2013 |
| 2013-06-12 | - | X-dag ordinarie utdelning |
| 2013-06-11 | - | Årsstämma |
| 2013-05-22 | - | Kvartalsrapport 2013-Q1 |
| 2013-02-13 | - | Bokslutskommuniké 2012 |
| 2012-11-27 | - | Kvartalsrapport 2012-Q3 |
| 2012-08-28 | - | Kvartalsrapport 2012-Q2 |
| 2012-06-14 | - | Årsstämma |
| 2012-05-23 | - | Kvartalsrapport 2012-Q1 |
| 2012-02-17 | - | Bokslutskommuniké 2011 |
| 2011-11-30 | - | Kvartalsrapport 2011-Q3 |
| 2011-08-29 | - | Kvartalsrapport 2011-Q2 |
| 2011-06-17 | - | X-dag ordinarie utdelning |
| 2011-06-16 | - | Årsstämma |
| 2011-05-30 | - | Kvartalsrapport 2011-Q1 |
| 2011-02-18 | - | Bokslutskommuniké 2010 |
Beskrivning
| Land | Norge |
|---|---|
| Lista | OAX Equities |
| Sektor | Hälsovård |
| Industri | Bioteknik |
Zona Nordic AB (ZN) has filed a complaint against Aqua Bio Technology ASA (ABT) in the Helsingborg District Court, claiming that ABT has not fulfilled its obligations under a settlement agreement from 2009. The claim is for damages valued at NOK 12 180 000 with the addition of interest, and has been calculated based on the assumed market value of the alleged remaining delivery obligation of ABT.
The settlement agreement stated that ABT had to pay MNOK 3 and supply ingredients for one of ZN's product lines as needed until 2017. ABT has paid any and all amounts due and fulfilled all orders from ZN during the term of this agreement.
The complaint appears to come as a result of ABT rejecting an offer to buy ZN's product line for a material cash payment. The purchase of the ZN product line was set as a condition by ZN, otherwise ZN would place a historically large order at the end of the term of the agreement. From a commercial perspective, ABT did not consider the product line to be interesting, and since ZN could not document their need for the ingredient, ABT chose to end the negotiations.
ZN's complaint is based on the fact that ZN placed an order, at the very end of the term, that corresponded to more than 8 times the accumulated volume during the 8-year term of the agreement. This order was placed at the same time as ABT delivered a volume of the ingredient equal to the accumulated orders over the past 8 years, while the ingredient's shelf life is only 2 years.
ABT rejects that there is a basis for any claim against the company.
For further information, please contact CEO Arvid Lindberg, telephone +47 9824 5410.
About Aqua Bio Technology ASA
Aqua Bio Technology (ABT) has launched several cosmetic ingredients being used in skin care products globally. Skin care is the fastest growing segment in the cosmetics industry, where ABTs ingredients have established a foothold. In addition to ingredients ABT also commercializes new technologies/skin care products through in-licensing agreements with third parties. Aqua Bio Technology is listed on Oslo Axess.
--
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Aqua Bio Technology via Globenewswire